mocetinostat
Phase 1- Indications
- Osteoarthritis
Company intelligence / Profile preview
Calibr-Skaggs Institute for Innovative Medicines
La Jolla, California, United Stateslinkedin.com ↗
- Ownership
- Private
- Employees
- ~174
- Development stage
- Phase 1
01
Overview
Calibr has advanced over ten programs into clinical development with several more in IND-enabling studies. Their portfolio includes first-in-class approaches such as switchable CAR-T therapies and novel small molecule or biologic candidates targeting a range of unmet medical needs from rare fibrotic disorders to metabolic syndrome. The institute’s self-sustaining model reinvests licensing revenues back into research to accelerate translation from bench to bedside[1][6].
- Therapeutic areas
- GastroenterologyPulmonologyMetabolic DisordersImmunologyEndocrinologyOncologyInfectious Diseases
- Modalities
- Small moleculesbiologicscell therapiesoral peptideslong-acting injectables
- Industry
- Academic Hospital/University/Research
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Merck & Co. ($90M initial funding/licensing option)[5]Bristol Myers Squibb (fibrosis collaboration/license)[10]AbbVie [6]Bill & Melinda Gates Foundation [6]ArkBio [2]
Beyond the preview
Go deeper on Calibr-Skaggs Institute for Innovative Medicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calibr-Skaggs Institute for Innovative Medicines.